Old Web
English
Sign In
Acemap
>
authorDetail
>
Andrew Provan
Andrew Provan
Royal London Hospital
Medicine
Immunology
Thrombocytopenic purpura
Splenectomy
Eltrombopag
4
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Integrated Analysis of Long Term Safety in Patients (pts) with Chronic Immune Thrombocytopenia (ITP) Treated with Romiplostim.
2012
Blood
Douglas B. Cines
Terry Gernsheimer
Jeffrey S. Wasser
Bertrand Godeau
Andrew Provan
Roger M. Lyons
Ivy Altomare
Xuena Wang
Paul Woodard
Show All
Source
Cite
Save
Citations (2)
Eltrombopag, an oral platelet growth factor, for treatment of chronic immune thrombocytopenic purpura (ITP): A randomized, double-blind, placebo-controlled trial
2007
The journal of supportive oncology
James B. Bussel
Gregory Cheng
Mansoor N. Saleh
Bethan Psaila
Lidia Kovaleva
Nicole L. Stone
Bhabita Mayer
Julian Jenkins
Andrew Provan
Show All
Source
Cite
Save
Citations (1)
Analysis of Bleeding in Patients with Immune Thrombocytopenic Purpura (ITP): A Randomized, Double-Blind, Placebo-Controlled Trial of Eltrombopag, an Oral Platelet Growth Factor.
2006
Blood
James B. Bussel
Gregory Cheng
Mansoor N. Saleh
Lidia Kovaleva
Nicole L. Stone
Bhabita Mayer
Julian Jenkins
Andrew Provan
Show All
Source
Cite
Save
Citations (25)
Study of Treatment Patterns and Consequences of Immune Thrombocytopenic Purpura (ITP).
2005
Blood
Maxine D. Fisher
Grace Yang
Lauren P. Burawski
Kelly M. Grotzinger
Andrew Provan
John Barron
Show All
Source
Cite
Save
Citations (0)
1